Oncology Antibiotics

Laboratory-produced drugs used to target and destroy cancerous cells. Therapeutic anticancer antibiotics have become an accepted treatment for certain types of cancer. These drugs bind specifically to primary and metastatic cancer cells to block cell growth, while limiting effects on surrounding healthy cells. Antibiotic medicines kill malignant cells by fragmenting the DNA in the cell nucleus and by oxidizing critical compounds which are necessary for the cell. For patients receiving chemotherapy, there is an increased risk of infection due to a low white blood cell count (neutropenia) caused by a toxic effect of chemotherapy on the bone marrow. Preventive antibiotic therapy before the development of fever prevents illness and death in people with a low white blood cell count after chemotherapy.

    Related Conference of Oncology Antibiotics

    February 07-08, 2022

    International Conference on Vaccine Research

    Paris, France
    March 21-22, 2022

    37th International Conference on Immunology

    Brussels, Belgium
    March 21-22, 2022

    15th Global Summit on Immunology and Cell Biology

    Tokyo, Japan
    March 30-31, 2022

    2nd European Congress on Virology and Immunology

    Paris, France
    April 11-12, 2022

    3rd International Conference on Immunology & Immunotherapies

    Singapore City, Singapore
    April 11-12, 2022

    17th International Conference on Allergy and Clinical Immunology

    Singapore City, Singapore
    May 02-03, 2022

    16th International Conference on European Immunology

    Zurich, Switzerland
    May 18-19, 2022

    4th World Conference on Vaccine and Immunology

    Osaka, Japan
    August 03-04, 2022

    Rheumatology 2022

    Zurich, Switzerland
    August 22-23, 2022

    4th World Congress on Vaccine and Immunology

    Toronto, Canada
    September 16-17, 2022

    International Conference on Immunology Research

    New York, USA

    Oncology Antibiotics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in